India targets Russia, Brazil, Netherlandsfor pharma export growth

India plans to increase pharmaceutical exports to Russia, the Netherlands and Brazil, aiming to expand its presence beyond the United States, its largest market, amid tariff-related concerns. India’s pharmaceutical industry is currently exempt from US President Donald Trump’s tariffs of up to 50% but the sector has been on edge due to the uncertainty surrounding the situation. The US accounts for slightly more than a third of India’s pharmaceutical exports, primarily comprising cheaper generic versions of popular drugs. Sales in the country rose 20% to approximately $10.5 billion in fiscal 2025. The idea is to diversify the export chain and increase market share in other countries. The United Kingdom is India’s second-largest export market, with $914 million in sales, followed by Brazil with $778 million. Exports to the Netherlands and Russia stood at $616 million and $577 million, respectively, in fiscal 2025, according to government data, as per a report.